Big Data in occupational medicine: the convergence of -omics sciences, participatory research and e-health.


Journal

La Medicina del lavoro
ISSN: 0025-7818
Titre abrégé: Med Lav
Pays: Italy
ID NLM: 0401176

Informations de publication

Date de publication:
19 Apr 2019
Historique:
received: 17 10 2018
accepted: 06 03 2019
entrez: 17 4 2019
pubmed: 17 4 2019
medline: 25 7 2019
Statut: epublish

Résumé

New occupational hazards and risks are emerging in our progressively globalized society, in which ageing, migration, wild urbanization and rapid economic growth have led to unprecedented biological, chemical and physical exposures, linked to  novel technologies, products and duty cycles. A focus shift from worker health to worker/citizen and community health is crucial. One of the major revolutions of the last decades is the computerization and digitization of the work process, the so-called "work 4.0", and of the workplace. To explore the roles and implications of Big Data in the new occupational medicine settings. Comprehensive literature search. Big Data are characterized by volume, variety, veracity, velocity, and value. They come both from wet-lab techniques ("molecular Big Data") and computational infrastructures, including databases, sensors and smart devices ("computational Big Data" and "digital Big Data"). In the light of novel hazards and thanks to new analytical approaches, molecular and digital underpinnings become extremely important in occupational medicine. Computational and digital tools can enable us to uncover new relationships between exposures and work-related diseases; to monitor the public reaction to novel risk factors associated to occupational diseases; to identify exposure-related changes in disease natural history; and to evaluate preventive workplace practices and legislative measures adopted for workplace health and safety.

Sections du résumé

BACKGROUND BACKGROUND
New occupational hazards and risks are emerging in our progressively globalized society, in which ageing, migration, wild urbanization and rapid economic growth have led to unprecedented biological, chemical and physical exposures, linked to  novel technologies, products and duty cycles. A focus shift from worker health to worker/citizen and community health is crucial. One of the major revolutions of the last decades is the computerization and digitization of the work process, the so-called "work 4.0", and of the workplace.
OBJECTIVES OBJECTIVE
To explore the roles and implications of Big Data in the new occupational medicine settings.
METHODS METHODS
Comprehensive literature search.
RESULTS RESULTS
Big Data are characterized by volume, variety, veracity, velocity, and value. They come both from wet-lab techniques ("molecular Big Data") and computational infrastructures, including databases, sensors and smart devices ("computational Big Data" and "digital Big Data").
CONCLUSIONS CONCLUSIONS
In the light of novel hazards and thanks to new analytical approaches, molecular and digital underpinnings become extremely important in occupational medicine. Computational and digital tools can enable us to uncover new relationships between exposures and work-related diseases; to monitor the public reaction to novel risk factors associated to occupational diseases; to identify exposure-related changes in disease natural history; and to evaluate preventive workplace practices and legislative measures adopted for workplace health and safety.

Identifiants

pubmed: 30990472
doi: 10.23749/mdl.v110i2.7765
pmc: PMC7809972
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102-114

Références

J Occup Environ Hyg. 2015;12 Suppl 1:S41-54
pubmed: 26132979
Occup Med (Lond). 2015 Nov;65(8):632-7
pubmed: 26503978
J Bioeth Inq. 2017 Dec;14(4):485-488
pubmed: 29119459
Regul Toxicol Pharmacol. 2017 Dec;91 Suppl 1:S3-S13
pubmed: 28958911
Adv Exp Med Biol. 2013;735:283-300
pubmed: 23402035
PLoS One. 2016 Sep 20;11(9):e0161389
pubmed: 27649530
Annu Rev Public Health. 2017 Mar 20;38:215-239
pubmed: 28384083
JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72
pubmed: 27287964
Telemed J E Health. 2013 Dec;19(12):967-72
pubmed: 24083368
Am J Ind Med. 2010 Apr;53(4):361-71
pubmed: 20066672
Hum Genomics. 2017 Dec 08;11(1):32
pubmed: 29221465
J Med Internet Res. 2009 Mar 27;11(1):e11
pubmed: 19329408
Chest. 2015 Jan;147(1):224-231
pubmed: 25560860
PLoS One. 2014 Dec 03;9(12):e114483
pubmed: 25469901
Occup Environ Med. 2010 Feb;67(2):136-43
pubmed: 19933307
Ann Intern Med. 2016 Aug 16;165(4):262-9
pubmed: 27240022
Data Brief. 2016 Nov 13;10:457-464
pubmed: 28054008
J Occup Environ Med. 2017 Jun;59(6):578-587
pubmed: 28598934
PLoS One. 2015 May 07;10(5):e0126054
pubmed: 25951622
Inhal Toxicol. 2014 Feb;26(3):141-65
pubmed: 24517839
Sci Rep. 2017 Mar 30;7:44829
pubmed: 28358042
Am J Pathol. 2004 May;164(5):1807-15
pubmed: 15111327
PLoS One. 2015 Oct 27;10(10):e0141185
pubmed: 26505756
BMC Public Health. 2017 May 9;17(1):372
pubmed: 28482822
N Engl J Med. 2007 Dec 6;357(23):2348-58
pubmed: 18057337
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011 Jul;29(3):223-49
pubmed: 21929381
J Am Coll Radiol. 2018 Mar;15(3 Pt A):452-457
pubmed: 29290595
Nurs Sci Q. 2017 Oct;30(4):300-302
pubmed: 28934045
Implement Sci. 2017 Dec 19;12(1):150
pubmed: 29258551
Occup Med (Lond). 2015 Nov;65(8):615-25
pubmed: 26446523
Acad Med. 2012 Apr;87(4):403-10
pubmed: 22361790
Lancet Respir Med. 2017 May;5(5):445-455
pubmed: 28089118
Mil Med. 2015 Oct;180(10 Suppl):34-48
pubmed: 26444891
JMIR Med Inform. 2016 Nov 21;4(4):e38
pubmed: 27872036
Drug Saf. 2018 Feb;41(2):143-149
pubmed: 28840504
Respir Res. 2017 Oct 17;18(1):178
pubmed: 29041938
Accid Anal Prev. 2016 Aug;93:299-309
pubmed: 26614050
Occup Med (Lond). 2015 Nov;65(8):638-41
pubmed: 25979735
J Occup Environ Med. 2013 Dec;55(12 Suppl):S52-7
pubmed: 24284749
PLoS One. 2016 Aug 02;11(8):e0159885
pubmed: 27482907
Patient Prefer Adherence. 2013 Apr 24;7:353-9
pubmed: 23650443
Mil Med. 2015 Oct;180(10 Suppl):67-75
pubmed: 26444894
Occup Med (Lond). 2015 Nov;65(8):682-92
pubmed: 26503981
Comput Intell Neurosci. 2017;2017:6925138
pubmed: 28337216
J Prev Med Hyg. 2015 Aug 05;56(2):E102-10
pubmed: 26789987
Proteomics Clin Appl. 2014 Apr;8(3-4):258-68
pubmed: 24415579
Respir Med. 2015 Sep;109(9):1089-104
pubmed: 26073963
Am J Public Health. 2009 Nov;99 Suppl 3:S531-8
pubmed: 19890153
Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1847-50
pubmed: 16103423
Environ Model Softw. 2015 Dec 1;74:238-246
pubmed: 26644778
Saf Health Work. 2016 Jun;7(2):143-9
pubmed: 27340602
Clin Proteomics. 2016 Jan 22;13:2
pubmed: 26807072
PLoS One. 2017 May 4;12(5):e0176680
pubmed: 28472171
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012 Jun;30(6):408-12
pubmed: 22931765
Toxicol Sci. 2013 Apr;132(2):307-16
pubmed: 23358196
Nucleic Acids Res. 2017 Jan 4;45(D1):D979-D984
pubmed: 27924041
Ergonomics. 2015;58(5):659-73
pubmed: 25849898
Environ Int. 2017 Nov;108:127-136
pubmed: 28843141
PLoS One. 2012;7(10):e46091
pubmed: 23056237
PLoS One. 2016 Nov 2;11(11):e0166051
pubmed: 27806115
Accid Anal Prev. 2008 Jul;40(4):1468-79
pubmed: 18606280
Med Lav. 2017 Jun 28;108(3):167-173
pubmed: 28660869
Biomarkers. 2011 Mar;16(2):181-91
pubmed: 21231887
PLoS One. 2012;7(1):e30221
pubmed: 22253921
Int J Environ Res Public Health. 2013 Sep 27;10(10):4607-27
pubmed: 24084672
J Mol Biol. 2012 Oct 5;422(5):595-606
pubmed: 22721953
Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):81-5
pubmed: 26499421
Curr Environ Health Rep. 2017 Dec;4(4):463-471
pubmed: 28983874
Occup Environ Med. 2008 Jan;65(1):32-7
pubmed: 17728406
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):142-151
pubmed: 27576363
Appl Ergon. 2016 Mar;53 Pt B:298-311
pubmed: 26553303

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH